This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Promimic AB (publ)
5/15/2025
Hello and welcome to our presentation of the first quarter of 2025. A quarter with high activity, great focus on strategic business and of course continued research on the development side, where we invest to reach both new customers and new market segments. What would you like to share with us?
First of all, I would like to share that we have two new license agreements. We have one within the market segment Spine, i.e. back implants, which is our largest business area. And the other is a strategic license and collaboration agreement with a company called Linkotech, which is one of the major subcontractors within the orthopaedic area. It is a framework agreement that we can use to develop different application areas and products together with Linkotech.
That's right, a lot of good news. Our customers have also increased the number of approved products to a total of 59 on the market, and these are existing customers.
You're reading a preview of the PRO.ST Q1 2025 earnings call.
Free account.